Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
Leslee J. Shaw(American Institute for Economic Research), Ami E. Iskandrian(AstraZeneca (United Kingdom)), Rodica Pop‐Busui(University of Michigan), Raymond J. Gibbons(Mayo Clinic), Raymond Taillefer(Université de Montréal), Veronica Sansing(University of Pittsburgh), Bernard Chaitman(Saint Louis University), Manuel D. Cerqueira(Cleveland Clinic), George Beller(University of Virginia), Maria M. Brooks, Jaekyeong Heo(Allegheny College), Andrew D. Althouse(University of Pittsburgh)
Cited by 157
Related Papers
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k
ACC/AHA guidelines for coronary artery bypass graft surgery
|Journal of the American College of Cardiology|1999|2k
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
|Circulation|2011|1.8k
ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary
|Journal of the American College of Cardiology|2002|1.7k
Liberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery
|New England Journal of Medicine|2011|1.3k